Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bolwell

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Bone Marrow Transplantation|August 19, 2007
Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous leukemiaM Kalaycio, L Rybicki, B Pohlman, et al.
Bone Marrow Transplantation|March 23, 2010
Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCTD M Mickelson, L Sproat, R Dean, et al.
Bone Marrow Transplantation|February 2, 2000
High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipientsR Avery, B Pohlman, K Adal, et al.
Bone Marrow Transplantation|March 24, 2015
Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whitesB K Hamilton, L Rybicki, M Sekeres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
High-dose thiotepa with autologous bone marrow transplantation for metastatic malignant melanoma: results of phase I and II studies of the North American Bone Marrow Transplantation GroupS N Wolff, R H Herzig, J W Fay, et al.
Bone Marrow Transplantation|June 11, 2013
Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantationB K Hamilton, B Bolwell, M Kalaycio, et al.
Bone Marrow Transplantation|January 11, 2005
Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical courseR Avery, M Kalaycio, B Pohlman, et al.
Bone Marrow Transplantation|February 1, 1996
Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSFC S Rosenfeld, B Bolwell, A LeFever, et al.
Blood Cancer Journal|August 29, 2015
Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort studyB K Hamilton, L Rybicki, H Haddad, et al.
Bone Marrow Transplantation|January 25, 2011
Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantationS Malik, B Bolwell, L Rybicki, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|August 19, 2007
Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous leukemiaM Kalaycio, L Rybicki, B Pohlman, et al.
Bone Marrow Transplantation|March 23, 2010
Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCTD M Mickelson, L Sproat, R Dean, et al.
Bone Marrow Transplantation|February 2, 2000
High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipientsR Avery, B Pohlman, K Adal, et al.
Bone Marrow Transplantation|March 24, 2015
Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whitesB K Hamilton, L Rybicki, M Sekeres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
High-dose thiotepa with autologous bone marrow transplantation for metastatic malignant melanoma: results of phase I and II studies of the North American Bone Marrow Transplantation GroupS N Wolff, R H Herzig, J W Fay, et al.
Bone Marrow Transplantation|June 11, 2013
Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantationB K Hamilton, B Bolwell, M Kalaycio, et al.
Bone Marrow Transplantation|January 11, 2005
Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical courseR Avery, M Kalaycio, B Pohlman, et al.
Bone Marrow Transplantation|February 1, 1996
Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSFC S Rosenfeld, B Bolwell, A LeFever, et al.
Blood Cancer Journal|August 29, 2015
Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort studyB K Hamilton, L Rybicki, H Haddad, et al.
Bone Marrow Transplantation|January 25, 2011
Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantationS Malik, B Bolwell, L Rybicki, et al.
Pageof 5